×

Tag: Alex Zhavoronkov

Debate
A significant debate has originated regarding the inclusion of MG2A, a code for old age, in the ICD-11 for Mortality and Morbidity Statistics. What is the ICD-11? The 11th revision of the International Classification of Diseases, which goes into effect this month, is managed by the World Health Organization. Its stated purpose is twofold: allows...
Deep Longevity
Today, we have a bit more positive news with the announcement that Deep Longevity has added LifeHub and LifeClinic to its network of longevity-focused companies. This company plans to use multiple AI-based biological aging clocks to test a variety of longevity interventions, including supplements, drugs, and lifestyle choices. Teaming up to offer longevity healthcare This...
Longevity Therapeutics banner
We continue our coverage of Longevity Therapeutics 2021 and bring you part 2 of day 1. Dr. Steven Braithwhite - Chief Scientific Officer, Alkahest Steven Braithwhite from Alkahest gave an update on the company’s ongoing clinical trials. Alkahest has been sifting plasma proteome in search for proteins that decrease or increase with age (read our...
Taisho Pharmaceutical logo
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have agreed to collaborate on AI-powered drug discovery focused on identifying molecules to remove problematic senescent cells. Why we Age: Cellular SenescenceAs your body ages, more...
Young.ai logo
A new app created by Hong Kong-based Deep Longevity might help you stay in your prime longer, keep your mind sharp, and maintain habits that keep your biological age lower than your chronological age. Introducing Young.ai It has been an increasing trend in recent years for companies to develop health and fitness apps that track...
Few things in aging research are ever straightforward, and today's topic is no exception, as two researchers enjoy some back and forth regarding whether and how the World Health Organization (WHO) should recognize the aging processes as a disease. Proposing a new framework to facilitate development of rejuvenation therapies Back in November 2019, an international...